Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Results
Phase 2
This trial was for people with chronic myeloid leukaemia. It looked at adding a targeted drug to the targeted drug people were already taking.
It was open to people with chronic myeloid leukaemia (CML):
whose treatment had stopped working
that had the and is in the chronic phase stage or accelerated phase stage
Cancer Research UK supported this trial.
Recruitment start: 29 July 2020
Recruitment end: 12 November 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mhairi Copland
Cancer Research UK
University of Glasgow
NHS Greater Glasgow and Clyde
This is Cancer Research UK trial number CRUK/17/016.
Last reviewed: 7 January 2022
CRUK internal database number: 16165
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
